Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells.

Abstract

Natural killer/T-cell lymphoma (NKTL) is a highly aggressive disease. Despite the use of various treatment regimens, the prognosis of NKTL is poor, and new treatment strategies need to be determined. Because of the significant survival potential, nuclear factor (NF)-kappaB has become one of the major targets for drug development. In this study, we explored… (More)

Topics

  • Presentations referencing similar topics